Substance P at the Neuro-Immune Crosstalk in the Modulation of Inflammation, Asthma and Antimicrobial Host Defense
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
13
Page:
112-120
Author(s):
Jia Sun and Madhav Bhatia
Cardiovascular Effects of Current and Future Anti-Obesity Drugs
Journal:
Current Vascular Pharmacology
Volume:
12
Page:
493-504
Author(s):
Simon Comerma-Steffensen, Martin Grann, Charlotte U. Andersen, Jorgen Rungby and Ulf Simonsen
Nanocarriers for Respiratory Diseases Treatment: Recent Advances and Current Challenges
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
1133-1147
Author(s):
Adriana Trapani, Sante Di Gioia, Stefano Castellani, Annalucia Carbone, Gennara Cavallaro, Giuseppe Trapani and Massimo Conese
Aldose Reductase: A Multi-disease Target
Journal:
Current Enzyme Inhibition
Volume:
10
Page:
2-12
Author(s):
Jaiprakash N. Sangshetti, Rashmi S. Chouthe, Nikhil S. Sakle, Indrajeet Gonjari and Devanand B. Shinde
CD147: A Novel Modulator of Inflammatory and Immune Disorders
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2138-2145
Author(s):
X. Zhu, Z. Song, S. Zhang, A. Nanda and G. Li
Type 2 Innate Lymphoid Cells in Allergic Disease
Journal:
Current Immunology Reviews (Discontinued)
Volume:
9
Page:
214-221
Author(s):
Sean Lund, Hannah H. Walford and Taylor A. Doherty
Atopy and Role of Mast Cells in IgE-Mediated Allergic Diseases
Journal:
Current Immunology Reviews (Discontinued)
Volume:
9
Page:
249-260
Author(s):
Guillermina Yanek Jiménez-Andrade
Polymeric Drug Delivery Approaches for Colon Targeting: A Review
Journal:
Drug Delivery Letters
Volume:
4
Page:
38-48
Author(s):
Apninder Kaur, Amarjeet Kaur, Vishav P. Kaur, Manpreet Kaur and Ramchandra S. Murthy
Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
Journal:
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume:
1
Page:
24-31
Author(s):
Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu
Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma
Journal:
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume:
1
Page:
2-10
Author(s):
Lawren C. Wu, Joseph R. Arron, Jeffrey M. Harris, John G. Matthews and Karin Rosen